Feb 5- A federal judge on Friday said Allergan Plc's planned generic version of a drug meant to treat epilepsy infringed patents belonging to Supernus Pharmaceuticals Inc.. They closed up $2.00, or 19.7 percent, at $12.13 on the Nasdaq. District Judge Renée Marie Bumb in Camden, New Jersey said Allergan's proposed generic infringed two of the three Supernus...» Read More
Hewlett-Packard sued computer maker Acer on Tuesday accusing the company of illegally using patented HP technology in a variety of desktops, laptops and displays sold in the U.S.
Hung up on Vonage: It’s usually easy to recognize a story worthy of our immediate attention. It’s not always so easy to answer the questions that come up from the first few dribs and drabs of information. This is one of the key minefields one must traverse in the daily business of the Breaking News Desk.
The eight-member jury assessed Vonage $58 million in past damages and ordered it to pay a 5.5% royalty rate on Vonage sales going forward.
A U.S. federal judge dismissed Alcatel-Lucent's patent claim against Microsoft over technology that converts speech into text.
The U.S. patent process takes an average 44 months -- a woefully slow rate for the rapidly evolving technology sector. That's just one of the challenges being tackled at the first-ever Technology Policy Summit in San Jose. CNBC's Silicon Valley Bureau Chief Jim Goldman reports.
The battle between software giants Microsoft and AT&T rumbles on, as Microsoft prepares to defend itself in front of the U.S. Supreme Court against AT&T’s claim that its patent has been infringed. The outcome of this latest step, which rests on a technicality involving outsourcing, will be hugely significant in the case that will make the difference of billions of dollars to the software industry.
The companies also agreed to conclude their patent litigation, which involved imaging technologies, Kodak said.
The Washington Research Foundation has sued mobile phone makers Nokia, Samsung Electronics and Matsushita-owned Panasonic for infringing on a patent for wireless Bluetooth technology.
Private generic drugmaker Ratiopharm International had challenged the patent, which led to the decision.